Shree Health Remedies

Trastuzumab (Eleftha 440 mg Injection) is a targeted anticancer medicine used to treat cancers that overexpress the HER2 (human epidermal growth factor receptor 2) protein. It is commonly prescribed for HER2-positive breast cancer, both in early-stage and metastatic cases, and may be used alone or in combination with chemotherapy. Trastuzumab works by specifically binding to the HER2 receptors on cancer cells, slowing their growth and helping the immune system destroy them. It is also used in HER2-positive metastatic gastric (stomach) cancer. Eleftha 440 mg Injection is administered intravenously under medical supervision, usually at scheduled intervals, and patients are closely monitored during treatment due to potential side effects such as infusion reactions and effects on heart function.

XTANE 25 mg Tablets contain Exemestane, an oral hormonal therapy used in the treatment of Breast Cancer, especially in postmenopausal women with hormone receptor-positive (HR+) breast cancer. Exemestane works by blocking the enzyme aromatase, which is responsible for converting androgens into estrogen in the body. By lowering estrogen levels, it helps slow or stop the growth of estrogen-dependent breast cancer cells. XTANE 25 mg is usually taken once daily after a meal, as prescribed by an oncologist, and may be used after surgery, radiation, or prior hormonal therapy such as tamoxifen. Common side effects include hot flashes, joint pain, fatigue, increased sweating, and mild bone thinning, so regular monitoring of bone health and hormone-related effects is recommended during treatment.

Fulvestrant 250 mg Injection contains Fulvestrant, a hormonal therapy used to treat Breast Cancer, specifically in postmenopausal women with hormone receptor-positive (HR+) locally advanced or metastatic disease. Fulvestrant works by binding to estrogen receptors on cancer cells, blocking estrogen’s effect and promoting degradation of the receptors, which slows or stops the growth of estrogen-dependent tumors. It is administered as an intramuscular injection, typically in the buttocks, on a schedule of days 1, 15, 29, and then once monthly thereafter. Common side effects may include injection site pain, nausea, fatigue, hot flashes, headache, and mild liver function changes, so regular monitoring by a healthcare provider is recommended during treatment.

ANTREOL 1 – 10 Tablet is a prescription medication whose active ingredient is anastrozole 1 mg, belonging to a class of drugs known as aromatase inhibitors. It is mainly used in the treatment of hormone receptor-positive breast cancer in postmenopausal women, where the cancer cells depend on the female hormone estrogen to grow. By blocking the aromatase enzyme, anastrozole lowers estrogen production in the body, which helps slow or stop the growth of tumor cells and reduce the risk of cancer recurrence after surgery, radiation, or chemotherapy. 

Obnyx 40 mg Capsules contain Enzalutamide, an anti-cancer medicine used in the treatment of advanced Prostate Cancer, particularly metastatic or castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Enzalutamide works by blocking the action of androgens (male hormones like testosterone) at the androgen receptor, thereby slowing or stopping the growth and spread of prostate cancer cells. Obnyx 40 mg capsules are taken orally, usually once daily as prescribed by an oncologist, and may be used alone or alongside other hormone therapies such as medical or surgical castration. Common side effects can include fatigue, hot flashes, high blood pressure, dizziness, and an increased risk of falls, so regular medical monitoring is essential during treatment.

Lenshil 4 mg Capsules contain Lenvatinib, an oral targeted therapy used to treat certain types of advanced cancers. It is commonly prescribed for Thyroid Cancer (radioiodine-refractory differentiated thyroid cancer), Renal Cell Carcinoma, and in combination with other agents for Hepatocellular Carcinoma. Lenvatinib works by inhibiting multiple protein kinases involved in tumor growth and blood vessel formation (angiogenesis), thereby slowing tumor progression and spread. Lenshil 4 mg is taken orally, usually once daily as prescribed by an oncologist, and dosage may be adjusted based on tolerance. Common side effects include high blood pressure, fatigue, diarrhea, decreased appetite, nausea, and proteinuria, so regular monitoring of blood pressure, kidney function, and overall health is essential during treatment.

Aermotraz (Anastrozole) 1 mg tablets are used to treat hormone-dependent breast cancer in postmenopausal women by reducing estrogen levels in the body. They may also be prescribed in certain cases for hormonal imbalance under medical supervision.

Aermotraz (Anastrozole) 1 mg tablets are used to treat hormone-dependent breast cancer in postmenopausal women by reducing estrogen levels in the body. They may also be prescribed in certain cases for hormonal imbalance under medical supervision.

Anastrabol 1 mg (Anastrozole) is an oral medication containing anastrozole, a non‑steroidal aromatase inhibitor. It is primarily prescribed for the treatment of hormone receptor‑positive breast cancer in postmenopausal women, where it works by reducing estrogen production in the body. By lowering estrogen levels, it helps slow or stop the growth of estrogen‑dependent tumors. In certain medical situations, it may also be used to manage conditions related to excess estrogen. This medicine should be taken strictly under medical supervision, as potential side effects can include joint pain, bone density loss, hot flashes, and changes in cholesterol levels.

ANA‑ASH 1 mg tablet is a prescription medicine containing anastrozole, which is used mainly in the treatment of hormone‑dependent breast cancer in postmenopausal women. Anastrozole belongs to a class of drugs called aromatase inhibitors, and it works by blocking the enzyme aromatase that the body uses to produce estrogen. Since certain types of breast cancer cells need estrogen to grow, lowering estrogen levels helps slow or stop the growth of those hormone‑sensitive tumors.

Anaridex 1 mg (anastrozole) tablets are a prescription hormone‑therapy medicine used primarily in the treatment of certain types of breast cancer in women who have completed menopause (the cessation of menstrual periods). They belong to a class of drugs known as aromatase inhibitors, which work by blocking the aromatase enzyme that the body uses to make estrogen, thereby lowering estrogen levels in the body; because some breast cancer cells rely on estrogen to grow, this reduction helps slow or stop the growth and spread of hormone‑sensitive tumors. Anaridex may be used alone or in combination with other treatments such as surgery or radiation and is often prescribed for early‑stage breast cancer or advanced disease that has spread beyond the breast in postmenopausal women, and in some cases to help reduce the chance of cancer returning after initial therapy. The tablet is taken once daily as directed by a doctor, and regular monitoring by a healthcare provider is important due to possible side effects such as hot flashes, nausea, fatigue and bone‑related changes. 

Letrobol 2.5 mg (Letrozole) is an oral medication containing letrozole, a non‑steroidal aromatase inhibitor. It is primarily prescribed for the treatment of hormone receptor‑positive breast cancer in postmenopausal women by reducing estrogen production in the body, thereby helping slow or stop tumor growth. In certain cases, it may also be used in fertility treatment protocols to help induce ovulation under specialist supervision. This medication should be taken only as directed by a qualified healthcare professional, as potential side effects may include joint pain, hot flashes, fatigue, and decreased bone mineral density with long‑term use.

Fempro 2.5 mg Tablets contain Letrozole, an oral hormonal therapy used primarily to treat Breast Cancer in postmenopausal women. Letrozole works by blocking the enzyme aromatase, which is responsible for converting androgens into estrogen in the body. By lowering estrogen levels, it slows or stops the growth of estrogen-dependent breast cancer cells. Fempro 2.5 mg is usually taken once daily, with or without food, as prescribed by an oncologist. Common side effects may include hot flashes, joint pain, fatigue, nausea, bone thinning (osteoporosis), and increased risk of fractures, so regular monitoring of bone health and hormone-related effects is recommended during treatment.

Nintedanib 100 mg capsules are used to treat certain types of lung diseases, mainly idiopathic pulmonary fibrosis (IPF), by slowing the scarring of lung tissue. They may also be prescribed for other chronic fibrosing interstitial lung diseases to help preserve lung function and slow disease progression.

Nindanib 150 mg (Nintedanib) capsules are used to slow the progression of certain lung diseases, primarily:

• Idiopathic Pulmonary Fibrosis (IPF) – a condition causing scarring of the lungs and breathing difficulties.

• Other chronic fibrosing interstitial lung diseases.

• Sometimes used for systemic sclerosis–associated interstitial lung disease (SSc-ILD).

Nintedanib 100 mg capsules (Nintedoc) are used to slow the progression of certain lung diseases. It is mainly prescribed for idiopathic pulmonary fibrosis (IPF), a condition that causes scarring of the lungs and difficulty in breathing. Nintedanib is also used in other chronic fibrosing interstitial lung diseases and systemic sclerosis–associated interstitial lung disease (SSc-ILD). It works by blocking enzymes involved in lung scarring, helping to reduce further lung damage. The medicine should be taken exactly as prescribed, and common side effects include diarrhea, nausea, and liver enzyme changes.

Letroheal 2.5 mg tablet is a prescription hormone‑therapy medicine used in the treatment of certain types of breast cancer, especially in postmenopausal women. Its active ingredient is letrozole, which belongs to a class of drugs called aromatase inhibitors. Letrozole works by blocking the aromatase enzyme that converts other hormones into estrogen, thereby lowering estrogen levels in the body. Because some breast cancers depend on estrogen to grow, reducing estrogen helps slow or stop the growth and spread of hormone‑sensitive tumor cells.

Calcium Leucovorin (Shilstine 50 mg Injection) is a folinic acid preparation used to reduce the toxic effects of certain chemotherapy medicines and to improve the effectiveness of others. It is most commonly administered after high-dose methotrexate therapy as a “rescue” treatment to protect normal cells from severe side effects without reducing the anticancer benefits. It is also used in cases of methotrexate overdose. When given together with 5-fluorouracil (5-FU), it enhances the effectiveness of chemotherapy, particularly in colorectal cancer and other gastrointestinal cancers. Additionally, it may be used to treat certain types of anemia caused by folic acid deficiency when oral supplementation is not appropriate. This injection is given intravenously or intramuscularly under medical supervision, with dosage depending on the medical condition and treatment protocol.

Cycloxan 500 Injection contains Cyclophosphamide, a chemotherapy medicine used to treat various types of cancer and certain autoimmune disorders.Cyclophosphamide works by interfering with the growth of rapidly dividing cells — such as cancer cells — helping to slow or stop tumor growth. It is commonly used as part of combination chemotherapy regimens for cancers including lymphoma, leukemia, breast cancer, ovarian cancer, and others. In some autoimmune diseases like severe rheumatoid arthritis or systemic lupus erythematosus, it may be used in lower doses to suppress an overactive immune system.

Leuprolide Acetate (Luprodex 3.75 mg Injection) is a long-acting gonadotropin-releasing hormone (GnRH) agonist used to manage hormone-dependent conditions. It works by reducing the production of sex hormones such as testosterone in men and estrogen in women. Luprodex 3.75 mg is commonly prescribed for the treatment of advanced prostate cancer, helping to slow or stop tumor growth by lowering testosterone levels. In women, it is used to treat endometriosis and uterine fibroids by decreasing estrogen production, which helps reduce pain, abnormal bleeding, and fibroid size. It is also used in the management of central precocious puberty (early onset puberty) in children by suppressing premature hormonal activity. Additionally, it may be used as part of assisted reproductive technology (ART) protocols to control ovulation. The injection is typically administered once monthly under medical supervision.

Fulvenat Injection contains Fulvestrant, a hormonal therapy used in the treatment of hormone receptor-positive advanced Breast Cancer in postmenopausal women. It is particularly prescribed for locally advanced or metastatic breast cancer that has progressed after prior anti-estrogen therapy. Fulvestrant works by binding to and blocking estrogen receptors on cancer cells and promoting their degradation, thereby slowing or stopping the growth of estrogen-dependent tumors. It is administered as an intramuscular injection, usually given in the buttocks on a scheduled dosing regimen (such as days 1, 15, 29, and then monthly). Common side effects may include injection site pain, nausea, fatigue, hot flashes, headache, and mild liver function changes, so regular medical monitoring is recommended during treatment.

Dactinomycin (Dacilon 0.5 mg Injection) is a chemotherapy medicine used to treat several types of cancers. It works by interfering with the growth of cancer cells by binding to DNA and preventing the cells from multiplying. Dacilon 0.5 mg Injection is commonly used in the treatment of Wilms’ tumor (a type of kidney cancer in children), rhabdomyosarcoma (a cancer of muscle tissue), Ewing’s sarcoma, and certain types of testicular cancer. It is also used in the management of gestational trophoblastic neoplasia (a rare tumor that develops from pregnancy-related tissue). Dactinomycin is usually given intravenously in a hospital setting under strict medical supervision, as it is a potent anticancer agent and requires careful dosing and monitoring to manage potential side effects.